Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSPECTIVES: Protelos for postmenopausal osteoporotic patients with previous therapies
ISRCTN80637249Phase 4Completed
- Sponsor
- Servier
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of strontium ranelate in postmenopausal osteoporosis, sponsored by Servier. Primary endpoints: Efficacy under routine conditions, Tolerability and 4 more. Started Feb 2009; status: completed.
02
Drugs
strontium ranelate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on ISRCTN80637249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN80637249.